Research venture capital in Iberia by matching your actual Spain or Portugal connection, investment stage and sector thesis. A Portuguese energy startup and a Spanish biotech team may both appear in a regional directory but need different capital routes.
This guide compares 21 selected investors connected to Spain, Portugal or a wider European mandate. Some explicitly invest across Iberia; others have more specific company, sector or fund criteria.
Map the company connection before the fund list
- Identify current facts. Record company, founder, team and customer locations separately.
- Read the geographic mandate. Bynd describes an Iberian founder or team connection; Portugal Ventures specifies a Portuguese registered office.
- Choose the financing route. Direct venture investment, corporate investment and bank-backed programs are distinct.
- Match the actual sector and entry stage. A later portfolio round does not prove the current fund's first-investment criteria.
Compare 21 Iberian investor routes
Use provider type, stage and geographic connection together. An office address is not a promise of eligibility. Where the current source does not establish a precise entry stage, the table leaves that question open.
Selected Spain- and Portugal-connected investment routes researched October 29, 2026. Each vehicle has its own mandate and application process. On small screens, scroll the table sideways to see every column.
| Investor or network | Provider type | Stage | Sector focus | Geographic connection |
|---|---|---|---|---|
| 4Founders Capital | Entrepreneur-led venture firm | Pre-seed through Series A+ | Scalable technology businesses | Barcelona office; internationally ambitious founders |
| Asabys Partners | Healthcare and life-sciences investment firm | Confirm the relevant fund and development stage | Healthcare and life-sciences innovation | Barcelona-based investment team |
| BStartup | Bank-backed startup investment route | Seed investment; confirm current process | Technology and innovative startups | Banco Sabadell startup ecosystem in Spain |
| Criteria Capital Risc | Specialist venture-management platform | Early-stage; biotech also includes growth | Technology; biotechnology; health | CriteriaCaixa venture platform in Spain |
| Encomenda Smart Capital | Early-stage venture firm | Pre-seed and seed for initial investments | Technology-based businesses | Companies arising in Spain with international ambition |
| Nauta Capital | B2B software venture firm | Early-stage; current fund spans pre-seed to Series A | B2B software; enterprise technology; deep tech | European companies; Barcelona and London offices |
| Ship2B Ventures | Impact venture investor | Confirm the relevant fund and entry stage | Healthy ageing; children's health; climate transition | Barcelona-based investment platform |
| Ysios Capital | Biotechnology venture firm | Company and clinical-development stage specific | Innovative therapeutic drugs | Barcelona and San Sebastian offices; global biotech investing |
| Acurio Ventures | European venture firm | Seed and Series A in the current proposition | Technology companies; relevant team fit | Offices in Bilbao, Madrid and London; Europe-wide approach |
| JME Ventures | Seed-stage venture investor | Seed | Technology-enabled businesses across sectors | Published focus on Spain's startup companies |
| Kibo Ventures | Venture investment platform; separate PE strategy | Pre-Series A and Series A on the venture route | B2B; deep tech; AI; cybersecurity | European founder and technology mandate |
| Samaipata | European technology venture firm | Confirm current fund's entry stage | Technology products with network effects; current AI-related activity | Headquartered in Madrid; investing across Europe |
| Portugal Ventures | Public-backed venture investment platform | Pre-seed, seed and Series A; check the specific call | Digital technology; manufacturing; health; tourism | Startups with registered offices in Portugal |
| Indico Capital Partners | Venture and sustainability investment manager | Mostly pre-seed through Series A; selective later rounds | Software; AI; deep tech; health; ocean technology | Portuguese-, Spanish- and Italian-related companies |
| Armilar | Early-stage venture firm | Early stage; confirm current fund | Technology companies | Portuguese investment team and international portfolio; confirm current mandate |
| Faber | Specialist early-stage venture firm | Pre-seed and seed; strategy-specific later participation | Applied science; digital transformation; climate and ocean technology | Southern Europe with selective investments elsewhere in Europe |
| Shilling | Early-stage venture firm | Early-stage entry; confirm the relevant current fund | Technology companies; fund-specific | Portuguese venture platform; verify current company and market criteria |
| Bynd Venture Capital | Early-stage Iberian venture firm | Pre-seed and seed | Technology across software, consumer and sustainability | Founder or team based in Iberia |
| LC Ventures | Early-stage technology venture firm | Pre-seed and seed | Software-only solutions | Lisbon-based investor; confirm current market criteria |
| EDP Ventures | Corporate venture investor | Typically seed through Series B | Technology affecting the energy sector | Global energy strategy with Portuguese parent; confirm the company connection |
| Biovance Capital | Life-science venture investor | Seed and Series A | Biotechnology therapeutics | Europe with a stated Southern Europe focus |
Iberian reach and national criteria are different
Bynd explicitly describes an Iberian footprint, while Portugal Ventures describes startups with registered offices in Portugal. JME states a focus on Spain's startup companies, and Indico describes Portuguese-, Spanish- and Italian-related companies. Those are different criteria, not a single regional eligibility standard.
A manager's office is useful context. Confirm the relevant current fund and company requirements before outreach.
Compare software, science and energy theses
Nauta describes a B2B software approach; LC Ventures states a software-only focus. Asabys and Ysios describe healthcare or biotechnology investing, while Biovance states a therapeutics focus. EDP's venture strategy is centered on the energy sector.
Prepare buyer and product evidence for software; for scientific companies, distinguish the research result, remaining development risk and commercialization plan.
Identify the actual fund and first-investment stage
Bynd and LC describe pre-seed and seed; Portugal Ventures lists pre-seed through Series A; Faber presents early frontier technology strategies. An investor's later portfolio follow-on is not automatically the entry point for a new founder.
Count a manager once even if it has several funds. Bank-backed routes, corporate investors and independent venture firms may use different processes.
Use the regional view to plan market comparisons
Keep customers and company presence in Spain and Portugal in separate fields, then compare the fund's explicit criteria. A planned launch is not evidence of existing customer revenue.
Use the individual country guides for local context and this regional view to compare managers and cross-border questions without repeating the city articles.
Investor profiles and official routes
These profiles are a research aid, not a performance ranking. Read the current strategy and portfolio before sharing a deck. A public contact route does not establish that a firm has available allocation for your round.
4Founders Capital
Entrepreneur-led venture firm. Barcelona office; internationally ambitious founders. Its current criteria emphasize strong founder ownership, technical scalability and international ambition. Prepare the specific customer problem and the milestone the next round would finance; a large market alone does not show why this team can build the company.
4Founders Capital: official investment information
Asabys Partners
Healthcare and life-sciences investment firm. Barcelona-based investment team. A relevant starting point for a scientific or healthcare innovation, not a general consumer-software pitch. Explain what is demonstrated, the next development milestone and the clinical or commercial problem, then confirm which current fund evaluates that work.
Asabys Partners: official investment information · CONTACT
BStartup
Bank-backed startup investment route. Banco Sabadell startup ecosystem in Spain. Separate BStartup's investment activity from its banking services. A startup bank account or participation in an event does not establish that the equity team has reviewed the company; use the investment-specific information to prepare the conversation.
BStartup: official investment information
Criteria Capital Risc
Specialist venture-management platform. CriteriaCaixa venture platform in Spain. The legacy Caixa Capital Risc link now leads to the Criteria Capital Risc platform. Criteria Venture Tech and Criteria Bio Ventures have different technical and scientific jobs. Count the manager once, but identify the appropriate specialist vehicle on the shortlist.
Criteria Capital Risc: official investment information
Encomenda Smart Capital
Early-stage venture firm. Companies arising in Spain with international ambition. Its published approach explicitly connects early company building in Spain with global ambition. Bring the customer insight, technical product and a capital-efficient milestone plan. A later follow-on capability does not change the evidence needed for a first investment.
Encomenda Smart Capital: official investment information · Founder funding route
Nauta Capital
B2B software venture firm. European companies; Barcelona and London offices. Nauta's current founder criteria call for an operating B2B software product, even if pre-revenue. Show what users can already do with the product, who the buyer is and what has been learned; the published pitch page is for founders, not fund subscriptions.
Nauta Capital: official investment information · Official founder pitch page · Additional official strategy or location evidence
Ship2B Ventures
Impact venture investor. Barcelona-based investment platform. Use the current named impact priorities rather than a generic sustainability label. A founder should explain the business outcome and the impact evidence separately, including how the product changes the problem it claims to address.
Ship2B Ventures: official investment information · Get in touch
Ysios Capital
Biotechnology venture firm. Barcelona and San Sebastian offices; global biotech investing. Its current strategy focuses exclusively on innovative therapeutics addressing unmet medical need. General wellness, hospital workflow software and a new drug are different propositions; the company should establish a genuine therapeutic fit before preparing a diligence package.
Ysios Capital: official investment information · Contact us
Acurio Ventures
European venture firm. Offices in Bilbao, Madrid and London; Europe-wide approach. Acurio's current About page describes a European approach and several ways to participate in a round. Explain why the operating team and financing milestone fit its strategy; having a Spanish office does not make the mandate Spain-only.
Acurio Ventures: official investment information · Additional official strategy or location evidence
JME Ventures
Seed-stage venture investor. Published focus on Spain's startup companies. Its current site identifies seed-stage founders and Spain's company-building opportunity. Explain the product, early demand and use of the next round. Treat its wider investor network as potential support, not a guaranteed syndicate or introduction.
JME Ventures: official investment information · Contact
Kibo Ventures
Venture investment platform; separate PE strategy. European founder and technology mandate. The current venture page is more specific than the group's broad VC-and-PE homepage. Select the venture route for an early technology round and explain the buyer, technical differentiation and expansion case; the separate Kibo Nzyme strategy is not another seed fund.
Kibo Ventures: official investment information
Samaipata
European technology venture firm. Headquartered in Madrid; investing across Europe. Its current investment philosophy emphasizes network effects and European-led companies. Demonstrate the mechanism that makes the product more useful as participation grows. Operational platform support is separate from the investment decision and should not be presented as a promised commercial result.
Samaipata: official investment information · Founder deck and team contact · Additional official strategy or location evidence
Portugal Ventures
Public-backed venture investment platform. Startups with registered offices in Portugal. Its published investment strategy specifies a Portuguese registered office. Match the call, stage and company facts before applying; an Iberian label does not remove those criteria.
Portugal Ventures: official investment information
Indico Capital Partners
Venture and sustainability investment manager. Portuguese-, Spanish- and Italian-related companies. The published strategy identifies company connections to Portugal, Spain and Italy. Compare the actual technology or sustainability vehicle and confirm current criteria.
Indico Capital Partners: official investment information
Armilar
Early-stage venture firm. Portuguese investment team and international portfolio; confirm current mandate. Armilar describes an early-stage technology strategy and provides a founder pitch route. A portfolio example is context, not proof that a particular applicant qualifies.
Armilar: official investment information · Contact us
Faber
Specialist early-stage venture firm. Southern Europe with selective investments elsewhere in Europe. Faber describes frontier technology and a Southern European focus. Explain the technical result and commercialization milestone and check the current vehicle.
Faber: official investment information
Shilling
Early-stage venture firm. Portuguese venture platform; verify current company and market criteria. Shilling presents a founders fund and a pitch route. Use the actual fund strategy, rather than treating its founder community and investments as separate funds.
Shilling: official investment information
Bynd Venture Capital
Early-stage Iberian venture firm. Founder or team based in Iberia. Bynd explicitly states an Iberian founder or team connection. Check the actual investment criteria and current process directly.
Bynd Venture Capital: official investment information
LC Ventures
Early-stage technology venture firm. Lisbon-based investor; confirm current market criteria. LC Ventures describes pre-seed and seed software investing and an application route. A Lisbon office alone does not establish eligibility across all Iberian markets.
LC Ventures: official investment information
EDP Ventures
Corporate venture investor. Global energy strategy with Portuguese parent; confirm the company connection. EDP describes its energy-sector investment focus and distinguishes later follow-ons. A Portugal-based corporate investor does not imply every business is in mandate.
EDP Ventures: official investment information
Biovance Capital
Life-science venture investor. Europe with a stated Southern Europe focus. Biovance states a therapeutics thesis and discusses preclinical evidence and intellectual-property requirements. Verify the present fund and development fit directly.
Biovance Capital: official investment information
Worked example: a Portuguese energy company exploring Spain
Illustrative example, not an investment recommendation. A fictional Portuguese startup has an energy-efficiency prototype and two domestic pilots. A Spanish market entry is a plan, not current revenue.
Questions for the fictional company
| Research route | Possible relevance | Question to verify |
|---|---|---|
| Portugal Ventures | Portuguese registered-office criteria | Does the company fit an active call and its stage? |
| Bynd | Iberian founder or team connection | Does the company's stage match the current fund? |
| EDP Ventures | Energy-sector venture strategy | Is the product within the current technology thesis? |
| Faber | Southern European frontier technology | Does the technical result fit the relevant strategy? |
No named investor has reviewed the fictional company.
Copy your Iberian investor shortlist worksheet
Use one record for each investor and specific vehicle. Keep the source date beside your fit decision.
IBERIAN INVESTOR FIT CARD
Company, buyer and product: [facts you may share]
Founder, team and company locations: [actual facts]
Spain and Portugal customers: [evidence by market]
Next financing milestone: [proof to build]
Investor and vehicle: [name and fund]
Published geographic criteria: [source + date]
Stage and sector thesis: [source + date]
Investment route and open question: [details]
Owner and next research action: [details]Research the shortlist with Aurora, Claude or Codex
Give your AI teammate company facts you are authorized to share. Ask for sourced comparisons and open questions, not automatic introductions or outreach.
Be my Iberian investor-research teammate.
Company, buyer and shareable facts: [details]
Founder, team, company and customer locations: [facts]
Spain or Portugal expansion plans: [hypotheses, not current activity]
Next financing milestone: [proof]
Candidate managers and funds: [names]
Use current official sources for each fund's stage, sector and geographic mandate.
Distinguish explicit Iberian criteria from Portuguese or Spanish office locations.
Separate independent venture, corporate investment and bank-backed routes.
Deduplicate managers and identify missing evidence and next research actions.
Do not invent eligibility, available funding or introductions.
Do not contact investors or give personalized legal, tax or financial advice.Keep the resulting investor records, relationship context and next actions together in Finta. The investor-prospecting workflow covers the next execution step.
Methodology, research date and local guides
Research checked October 29, 2026 by the Finta Editorial Team with AI-assisted source review. We reconciled provider names from our existing city research and reviewed current official strategy, portfolio, location or founder-contact pages. Firms with multiple offices count once; angel networks count as networks, not one committed pooled fund. We distinguish local presence from investment mandate and company eligibility. We do not infer check sizes, investor returns, lead behavior or open allocation from a portfolio logo.
We reused source-backed Spanish provider research and reviewed current Portuguese investor and founder-route sources. The regional comparison distinguishes company and founder criteria from office locations. Managers with multiple funds or city appearances are counted once.
This selected directory is not exhaustive or a ranking; confirm the current fund and application process directly.
Informational purposes only. Finta is not a law firm or accounting firm. This is general information, not personalized financial, legal or tax advice. Discuss structures and tax consequences with your attorney or accountant.
This is a selected research directory, not an exhaustive register or sponsored ranking. Confirm the current vehicle, team and process directly before relying on a fit decision.
Make the next fundraising step specific
Choose a small set of defensible matches, record the open question, and assign the next action. Use our investor-shortlist guide and warm-introduction guide to prepare the conversation. A longer list should make the research better, not turn into an indiscriminate mailing list.